Neurobiological Technologies, Inc. (NTII)
Neurobiological Technologies, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in EmeryVille, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,702. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 11.9%. Its beta of 6.95 implies it has historically moved more than the broad market.
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.
Neurobiological Technologies, Inc. is most often compared with the following Healthcare names: